Clinical Trial Update: Cardiogenic Shock Integrated PHenotyping for Event Reduction

View source ↗

Summary

An ongoing clinical trial at Niguarda Hospital is investigating cardiogenic shock integrated phenotyping to reduce adverse events in heart failure patients. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Niguarda Hospital | Conditions: Heart Failure | Status: RECRUITING